Articles published by Context Therapeutics Inc.
Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates
March 22, 2023
Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer
December 08, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following